Differences in prognosis and efficacy of chemotherapy by p53 expression in triple-negative breast cancer.
Soo Youn BaeSeok Jin NamYongsik JungSae Byul LeeByung-Woo ParkWoosung LimSung Hoo JungHsien Wen YangSeung Pil JungPublished in: Breast cancer research and treatment (2018)
The prognosis of p53(+) TNBC has worse than p53(-) TNBC, but the risk for survival was significantly reduced with chemotherapy. It suggests that p53(+) TNBC would be more sensitive to chemotherapy than p53(-) TNBC.